HU007 in Patients With Dry Eye Syndrome

A multicenter, Randomized, Double blind, Restasis®-controlled Non-inferiority, Moisview® Eye Drops Controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome

Inclusion CriteriaAge over 19Corneal staining score(Oxford grading) ≥ 2 and Schirmer test ≤ 10mm/5min (If Schirmer test = 0mm/5min, Nasal stimulation schirmer test ≥ 3mm/5min) and TBUT test ≤10 in at least one of both eyesVolunteer who have had more than one symptom of dry eye disease for at least 3 month before screening visit.Exclusion Criteria:The patients with clinically significant ocular disorders affected the test resultCurrent or recent patients used dry eye syndrome medications (topical or systemic) that may affect the statusSBP ≥140mmHg or DBP ≥ 90mmHg or HbA1c>9%Wearing contact lenses within 72 hr of screening visitPregnancy or Breastfeeding